
Delcath Systems DCTH
$ 9.12
-0.87%
Annual report 2025
added 02-26-2026
Delcath Systems DPO Ratio 2011-2026 | DCTH
Annual DPO Ratio Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 58.2 | 871 | 707 | 656 | 1.01 K | 2.3 K | 2.79 K | 2 K | 394 | 224 | 938 | 458 | 8.58 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.58 K | 56 | 1.5 K |
Quarterly DPO Ratio Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 | 87.1 | 41.4 | - | 117 | 143 | 126 | - | 590 | 1.03 K | 1.12 K | - | 912 | 839 | 2.6 K | - | 485 | 555 | 1.23 K | - | 861 | 964 | 3.69 K | - | 2.4 K | 2.4 K | 5.82 K | - | 3.02 K | 3.2 K | 3.59 K | - | 2.04 K | 2.6 K | 925 | - | 484 | 361 | 361 | - | 288 | 189 | 354 | - | 1.37 K | 1.03 K | 652 | - | 2.31 K | 160 | 2.24 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.82 K | 41.4 | 1.32 K |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
Helius Medical Technologies
HSDT
|
362 | $ 2.01 | -6.94 % | $ 1.22 M | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.5 | -0.52 % | $ 732 M | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
Outset Medical
OM
|
11.1 | $ 3.49 | -1.13 % | $ 53.1 K | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
Sintx Technologies
SINT
|
223 | $ 2.41 | -5.82 % | $ 6.68 M | ||
|
CONMED Corporation
CNMD
|
57.3 | $ 36.24 | -2.27 % | $ 1.12 B | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Electromed
ELMD
|
47.8 | $ 24.5 | -0.65 % | $ 207 M | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
125 | $ 0.61 | -9.13 % | $ 33.2 M | ||
|
Aethlon Medical
AEMD
|
61.8 | $ 2.37 | 2.16 % | $ 3.7 M | ||
|
Sensus Healthcare
SRTS
|
14.7 | $ 4.04 | -4.38 % | $ 66 M | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Smith & Nephew plc
SNN
|
232 | $ 32.28 | -0.52 % | $ 23.8 B | ||
|
LivaNova PLC
LIVN
|
68 | $ 64.3 | 1.58 % | $ 3.51 B | ||
|
InspireMD
NSPR
|
72.3 | $ 1.73 | -1.14 % | $ 111 M | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.32 | -0.61 % | $ 1.53 B | ||
|
Penumbra
PEN
|
26.1 | $ 337.62 | 0.4 % | $ 13.1 B | ||
|
Stryker Corporation
SYK
|
70.1 | $ 333.54 | 1.83 % | $ 127 B | ||
|
MiMedx Group
MDXG
|
54.8 | $ 3.98 | -3.05 % | $ 588 M | ||
|
TELA Bio
TELA
|
31.8 | $ 0.73 | 5.78 % | $ 34.3 M | ||
|
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | ||
|
Myomo
MYO
|
34.8 | $ 0.68 | -2.34 % | $ 28.5 M | ||
|
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | ||
|
Tandem Diabetes Care
TNDM
|
35.7 | $ 23.13 | -4.66 % | $ 1.57 B | ||
|
Inspire Medical Systems
INSP
|
103 | $ 50.84 | -1.11 % | $ 1.49 B | ||
|
Pulmonx Corporation
LUNG
|
60.4 | $ 1.29 | -0.77 % | $ 52.5 M | ||
|
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
124 | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
19.8 | - | - | $ 2.07 B |